Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA in TAR
NCT07828262Phase 2Not yet recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Postoperative wound complications comparing TXA with Placebo (2 arms). Primary endpoint: Percentage of eligible participant enrollment at 12 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Postoperative wound complications
Beyond the preview
Go deeper on NCT07828262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828262.